Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals

HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef’s ability to antag...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 10; no. 1; p. 19416
Main Authors Toyoda, Mako, Kamori, Doreen, Tan, Toong Seng, Goebuchi, Kageaki, Ohashi, Jun, Carlson, Jonathan, Kawana-Tachikawa, Ai, Gatanaga, Hiroyuki, Oka, Shinichi, Pizzato, Massimo, Ueno, Takamasa
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 10.11.2020
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef’s ability to antagonize SERINC5 and thereby influence viral fitness in vivo . To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef’s ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo.
AbstractList HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef's ability to antagonize SERINC5 and thereby influence viral fitness in vivo. To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef's ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo.HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef's ability to antagonize SERINC5 and thereby influence viral fitness in vivo. To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef's ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo.
HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef’s ability to antagonize SERINC5 and thereby influence viral fitness in vivo . To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef’s ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo.
HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef's ability to antagonize SERINC5 and thereby influence viral fitness in vivo. To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef's ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo.
ArticleNumber 19416
Author Kamori, Doreen
Tan, Toong Seng
Carlson, Jonathan
Kawana-Tachikawa, Ai
Oka, Shinichi
Pizzato, Massimo
Ueno, Takamasa
Ohashi, Jun
Toyoda, Mako
Goebuchi, Kageaki
Gatanaga, Hiroyuki
Author_xml – sequence: 1
  givenname: Mako
  surname: Toyoda
  fullname: Toyoda, Mako
  organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University
– sequence: 2
  givenname: Doreen
  surname: Kamori
  fullname: Kamori, Doreen
  organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University
– sequence: 3
  givenname: Toong Seng
  surname: Tan
  fullname: Tan, Toong Seng
  organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University
– sequence: 4
  givenname: Kageaki
  surname: Goebuchi
  fullname: Goebuchi, Kageaki
  organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University
– sequence: 5
  givenname: Jun
  surname: Ohashi
  fullname: Ohashi, Jun
  organization: University of Tokyo
– sequence: 6
  givenname: Jonathan
  surname: Carlson
  fullname: Carlson, Jonathan
  organization: Microsoft Research
– sequence: 7
  givenname: Ai
  surname: Kawana-Tachikawa
  fullname: Kawana-Tachikawa, Ai
  organization: AIDS Research Center, National Institute of Infectious Diseases
– sequence: 8
  givenname: Hiroyuki
  surname: Gatanaga
  fullname: Gatanaga, Hiroyuki
  organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University, National Center for Global Health and Medicine
– sequence: 9
  givenname: Shinichi
  surname: Oka
  fullname: Oka, Shinichi
  organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University, National Center for Global Health and Medicine
– sequence: 10
  givenname: Massimo
  surname: Pizzato
  fullname: Pizzato, Massimo
  organization: Department of Cellular, Computational and Integrative Biology, University of Trento
– sequence: 11
  givenname: Takamasa
  surname: Ueno
  fullname: Ueno, Takamasa
  email: uenotaka@kumamoto-u.ac.jp
  organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33173092$$D View this record in MEDLINE/PubMed
BookMark eNp9kV1rHCEYhaUkNB_NH-hFEXqTm2n83Jm5KZQlTRZCCv26FVdfE8OMbtXZJf--bjdp01xEkFfxOYcj5wjthRgAobeUfKCEd2dZUNl3DWGkaWe8lc3mFTpkRMiGccb2npwP0EnOd6QuyXpB-9fogHPactKzQ5QX40r7BBbrpR98ucfR4WtwuERs4hQKJG0K_nb-dXE9l9hnrHOOxutSJRtfbnHVTqZeVoPOo8brajZ6jX3Al4ufjQ8OzJb1wfq1t5Me8hu07-qAk4d5jH58Pv8-v2yuvlws5p-uGiNaURomaSctsyBbEC1QYh1YIbQl0rTQCWOXkvTgDLjOUeGkNMz0XFDBOUgj-TH6uPNdTcsRrIFQkh7UKvlRp3sVtVf_vwR_q27iWrUzOWOSVIPTB4MUf02Qixp9NjAMOkCcsmJC9hXsGKvo-2foXZxSqN-rVEulrLuv1Lunif5GeeyjAt0OMCnmnMAp44suPm4D-kFRorbtq137qrav_rSvNlXKnkkf3V8U8Z0oVzjcQPoX-wXVbzoLw4o
CitedBy_id crossref_primary_10_1186_s12977_023_00618_7
crossref_primary_10_1371_journal_ppat_1010907
crossref_primary_10_3389_fcell_2022_856468
crossref_primary_10_1007_s00430_022_00732_x
crossref_primary_10_1128_jvi_00823_23
crossref_primary_10_1089_aid_2021_0055
crossref_primary_10_3390_v16020284
crossref_primary_10_3389_fcimb_2024_1516806
crossref_primary_10_1128_JVI_00634_21
Cites_doi 10.1093/bioinformatics/bti079
10.4049/jimmunol.1100316
10.1016/j.bbrc.2015.05.038
10.1073/pnas.0607622104
10.1371/journal.ppat.0030094
10.1074/jbc.M117.777714
10.1038/Nm0396-338
10.1128/JVI.69.1.579-584.1995
10.1128/Jvi.79.1.632-636.2005
10.1128/jvi.00904-07
10.1016/0092-8674(94)90360-3
10.1007/s13365-010-0001-6
10.1016/j.virol.2013.02.005
10.1126/science.270.5238.988
10.1097/QAD.0000000000002559
10.1186/1742-4690-10-100
10.1186/1742-4690-10-1
10.1099/vir.0.81775-0
10.1084/jem.179.1.101
10.1016/j.chom.2016.08.004
10.1016/j.virol.2014.08.009
10.1016/0092-8674(91)90097-i
10.1016/j.jviromet.2008.10.012
10.1016/j.virol.2006.03.044
10.1007/s00705-015-2480-5
10.1128/jvi.74.6.2907-2912.2000
10.1186/s12977-019-0510-1
10.1007/s00251-005-0048-3
10.1128/JVI.69.8.5048-5056.1995
10.1016/j.bbrc.2012.04.002
10.1186/1742-4690-8-50
10.7554/eLife.01754
10.1128/JVI.01998-12
10.1128/jvi.77.23.12430-12440.2003
10.1128/mBio.01516-15
10.1128/JVI.01246-16
10.1371/journal.pcbi.1000225
10.1038/nature15399
10.3390/cells8091020
10.1016/j.cub.2005.02.058
10.1128/jvi.01556-06
10.1128/jvi.77.19.10548-10556.2003
10.4049/jimmunol.178.9.5513
10.1093/emboj/16.23.6964
10.1038/nature15400
10.1128/jvi.77.2.1589-1594.2003
10.1016/j.jmb.2017.12.008
10.1126/science.1069660
10.1016/j.micinf.2009.09.009
10.1128/jvi.74.11.5310-5319.2000
10.1038/35004038
10.1186/1742-4690-9-s2-p269
10.1099/jgv.0.001201
10.1371/journal.pone.0006687
10.1128/JVI.68.5.2906-2914.1994
10.1016/j.celrep.2019.10.007
10.1128/JVI.01409-17
10.1016/j.jmb.2009.09.047
10.1074/jbc.M000536200
10.1128/JVI.01334-14
10.1128/JVI.01874-07
10.1128/JVI.01548-15
10.4049/jimmunol.180.2.1107
ContentType Journal Article
Copyright The Author(s) 2020
The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/s41598-020-76375-w
DatabaseName Springer Nature OA Free Journals (WRLC)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
MEDLINE
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
ExternalDocumentID PMC7656250
33173092
10_1038_s41598_020_76375_w
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Japan Agency for Medical Research and Development
  funderid: http://dx.doi.org/10.13039/100009619
– fundername: Japan Society for the Promotion of Science
  funderid: http://dx.doi.org/10.13039/501100001691
– fundername: ;
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c474t-25185d2de57e47e10dfed44ad05c7e84cdb509efcef8f14f55c2c9341433e5c53
IEDL.DBID 7X7
ISSN 2045-2322
IngestDate Thu Aug 21 13:32:31 EDT 2025
Tue Aug 05 11:30:13 EDT 2025
Wed Aug 13 02:52:26 EDT 2025
Thu Apr 03 06:59:11 EDT 2025
Tue Jul 01 02:46:50 EDT 2025
Thu Apr 24 22:59:35 EDT 2025
Fri Feb 21 02:38:52 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-25185d2de57e47e10dfed44ad05c7e84cdb509efcef8f14f55c2c9341433e5c53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2471557159?pq-origsite=%requestingapplication%
PMID 33173092
PQID 2471557159
PQPubID 2041939
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7656250
proquest_miscellaneous_2459625822
proquest_journals_2471557159
pubmed_primary_33173092
crossref_citationtrail_10_1038_s41598_020_76375_w
crossref_primary_10_1038_s41598_020_76375_w
springer_journals_10_1038_s41598_020_76375_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-11-10
PublicationDateYYYYMMDD 2020-11-10
PublicationDate_xml – month: 11
  year: 2020
  text: 2020-11-10
  day: 10
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2020
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Jin (CR23) 2019; 29
Fackler (CR39) 2006; 351
Venzke, Michel, Allespach, Fackler, Keppler (CR5) 2006; 80
Lindwasser (CR40) 2008; 82
Greenberg (CR16) 1997; 16
Mwimanzi (CR43) 2013; 439
Heigele (CR51) 2016; 20
Liu (CR32) 2000; 74
Casartelli (CR38) 2006; 87
Akari (CR15) 2000; 74
Mahiti, Brumme, Jessen, Brockman, Ueno (CR56) 2015; 463
Jere, Fujita, Adachi, Nomaguchi (CR49) 2010; 12
Ueno, Idegami, Motozono, Oka, Takiguchi (CR55) 2007; 178
Yamada (CR19) 2003; 77
Carlson (CR28) 2012; 86
Mwimanzi (CR57) 2013; 10
Miller, Warmerdam, Gaston, Greene, Feinberg (CR7) 1994; 179
Schindler (CR6) 2003; 77
Miller, Warmerdam, Page, Feinberg, Greene (CR11) 1995; 69
Pond, Frost, Muse (CR54) 2005; 21
Kestler (CR1) 1991; 65
Sudderuddin (CR37) 2020; 17
Ren, Park, Bonifacino, Hurley (CR18) 2014; 3
Mwimanzi (CR58) 2011; 8
Mann (CR42) 2013; 10
Pizzato (CR60) 2009; 156
de Sousa-Pereira (CR52) 2019; 100
Sood, Marin, Chande, Pizzato, Melikyan (CR14) 2017; 292
Hasan (CR24) 2012; 421
Williams, Roeth, Kasper, Filzen, Collins (CR31) 2005; 79
Schwartz, Marechal, LeGall, Lemonnier, Heard (CR8) 1996; 2
Mann (CR45) 2014; 468–470
Moore (CR63) 2002; 296
Moroco (CR50) 2018; 430
Toyoda (CR46) 2015; 89
Deacon (CR2) 1995; 270
Itoh (CR25) 2005; 57
Brumme (CR21) 2007; 3
Zhang (CR29) 2011; 187
Carlson (CR27) 2008; 4
Pizzato (CR33) 2007; 104
Trautz (CR61) 2016; 90
Brumme (CR62) 2009; 4
Gray (CR41) 2011; 17
Ueno (CR22) 2008; 180
Geels (CR30) 2003; 77
Aiken, Konner, Landau, Lenburg, Trono (CR3) 1994; 76
Chowers (CR9) 1994; 68
Mahiti (CR59) 2016; 7
Mwimanzi (CR47) 2018
Poe, Smithgall (CR48) 2009; 394
Chikata (CR26) 2012; 9
Piguet (CR17) 2000; 2
Michel, Allespach, Venzke, Fackler, Keppler (CR4) 2005; 15
Rosa (CR12) 2015; 526
Münch (CR35) 2007; 81
Meribe (CR53) 2015; 160
Usami, Wu, Gottlinger (CR13) 2015; 526
Cohen, Rangan, Chen, Smith, Baltimore (CR34) 2000; 275
Aiken, Trono (CR10) 1995; 69
Mwimanzi (CR36) 2020; 34
Ramirez (CR20) 2019
Kuang (CR44) 2014; 88
J Münch (76375_CR35) 2007; 81
SW Jin (76375_CR23) 2019; 29
A Jere (76375_CR49) 2010; 12
P Mwimanzi (76375_CR58) 2011; 8
MY Chowers (76375_CR9) 1994; 68
JM Carlson (76375_CR28) 2012; 86
M Mahiti (76375_CR56) 2015; 463
T Yamada (76375_CR19) 2003; 77
LX Liu (76375_CR32) 2000; 74
T Chikata (76375_CR26) 2012; 9
SC Meribe (76375_CR53) 2015; 160
SL Pond (76375_CR54) 2005; 21
MD Miller (76375_CR11) 1995; 69
NJ Deacon (76375_CR2) 1995; 270
N Michel (76375_CR4) 2005; 15
OT Fackler (76375_CR39) 2006; 351
Y Itoh (76375_CR25) 2005; 57
M Mahiti (76375_CR59) 2016; 7
Z Hasan (76375_CR24) 2012; 421
B Trautz (76375_CR61) 2016; 90
Y Usami (76375_CR13) 2015; 526
T Ueno (76375_CR22) 2008; 180
ZL Brumme (76375_CR21) 2007; 3
M Williams (76375_CR31) 2005; 79
Y Zhang (76375_CR29) 2011; 187
OW Lindwasser (76375_CR40) 2008; 82
CB Moore (76375_CR63) 2002; 296
GB Cohen (76375_CR34) 2000; 275
C Aiken (76375_CR3) 1994; 76
C Sood (76375_CR14) 2017; 292
ME Greenberg (76375_CR16) 1997; 16
P Mwimanzi (76375_CR57) 2013; 10
HW Kestler 3rd (76375_CR1) 1991; 65
V Piguet (76375_CR17) 2000; 2
JM Carlson (76375_CR27) 2008; 4
S Venzke (76375_CR5) 2006; 80
M Schindler (76375_CR6) 2003; 77
C Aiken (76375_CR10) 1995; 69
M Toyoda (76375_CR46) 2015; 89
A Rosa (76375_CR12) 2015; 526
H Akari (76375_CR15) 2000; 74
P Mwimanzi (76375_CR43) 2013; 439
A Heigele (76375_CR51) 2016; 20
H Sudderuddin (76375_CR37) 2020; 17
JA Moroco (76375_CR50) 2018; 430
MD Miller (76375_CR7) 1994; 179
M Pizzato (76375_CR33) 2007; 104
LR Gray (76375_CR41) 2011; 17
JA Poe (76375_CR48) 2009; 394
XT Kuang (76375_CR44) 2014; 88
T Ueno (76375_CR55) 2007; 178
JK Mann (76375_CR45) 2014; 468–470
F Mwimanzi (76375_CR47) 2018
O Schwartz (76375_CR8) 1996; 2
N Casartelli (76375_CR38) 2006; 87
ZL Brumme (76375_CR62) 2009; 4
P de Sousa-Pereira (76375_CR52) 2019; 100
JK Mann (76375_CR42) 2013; 10
PW Ramirez (76375_CR20) 2019
F Mwimanzi (76375_CR36) 2020; 34
M Pizzato (76375_CR60) 2009; 156
MJ Geels (76375_CR30) 2003; 77
X Ren (76375_CR18) 2014; 3
References_xml – volume: 21
  start-page: 676
  year: 2005
  end-page: 679
  ident: CR54
  article-title: HyPhy: Hypothesis testing using phylogenies
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bti079
– volume: 187
  start-page: 684
  year: 2011
  end-page: 691
  ident: CR29
  article-title: Multilayered defense in HLA-B51-associated HIV viral control
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1100316
– volume: 463
  start-page: 248
  year: 2015
  end-page: 254
  ident: CR56
  article-title: Dynamic range of Nef-mediated evasion of HLA class II-restricted immune responses in early HIV-1 infection
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2015.05.038
– volume: 104
  start-page: 6812
  year: 2007
  end-page: 6817
  ident: CR33
  article-title: Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.0607622104
– volume: 3
  start-page: e94
  year: 2007
  ident: CR21
  article-title: Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.0030094
– volume: 292
  start-page: 6014
  year: 2017
  end-page: 6026
  ident: CR14
  article-title: SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M117.777714
– volume: 2
  start-page: 338
  year: 1996
  end-page: 342
  ident: CR8
  article-title: Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
  publication-title: Nat. Med.
  doi: 10.1038/Nm0396-338
– volume: 69
  start-page: 579
  year: 1995
  end-page: 584
  ident: CR11
  article-title: Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry
  publication-title: J. Virol.
  doi: 10.1128/JVI.69.1.579-584.1995
– volume: 79
  start-page: 632
  year: 2005
  end-page: 636
  ident: CR31
  article-title: Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2
  publication-title: J. Virol.
  doi: 10.1128/Jvi.79.1.632-636.2005
– volume: 81
  start-page: 13852
  year: 2007
  end-page: 13864
  ident: CR35
  article-title: Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses
  publication-title: J. Virol.
  doi: 10.1128/jvi.00904-07
– volume: 76
  start-page: 853
  year: 1994
  end-page: 864
  ident: CR3
  article-title: Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90360-3
– volume: 17
  start-page: 82
  year: 2011
  end-page: 91
  ident: CR41
  article-title: CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates
  publication-title: J. Neurovirol.
  doi: 10.1007/s13365-010-0001-6
– volume: 439
  start-page: 74
  year: 2013
  end-page: 80
  ident: CR43
  article-title: Dynamic range of Nef functions in chronic HIV-1 infection
  publication-title: Virology
  doi: 10.1016/j.virol.2013.02.005
– volume: 270
  start-page: 988
  year: 1995
  end-page: 991
  ident: CR2
  article-title: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients
  publication-title: Science
  doi: 10.1126/science.270.5238.988
– volume: 34
  start-page: 1325
  year: 2020
  end-page: 1330
  ident: CR36
  article-title: An HIV-1 Nef genotype that diminishes immune control mediated by protective human leucocyte antigen alleles
  publication-title: Aids
  doi: 10.1097/QAD.0000000000002559
– volume: 10
  start-page: 100
  year: 2013
  ident: CR42
  article-title: Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-10-100
– volume: 10
  start-page: 1
  year: 2013
  ident: CR57
  article-title: Attenuation of multiple Nef functions in HIV-1 elite controllers
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-10-1
– volume: 87
  start-page: 2291
  year: 2006
  end-page: 2296
  ident: CR38
  article-title: The Pro78 residue regulates the capacity of the human immunodeficiency virus type 1 Nef protein to inhibit recycling of major histocompatibility complex class I molecules in an SH3-independent manner
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.81775-0
– volume: 179
  start-page: 101
  year: 1994
  end-page: 113
  ident: CR7
  article-title: The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.179.1.101
– volume: 20
  start-page: 381
  year: 2016
  end-page: 391
  ident: CR51
  article-title: The potency of Nef-mediated SERINC5 antagonism correlates with the prevalence of primate lentiviruses in the wild
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2016.08.004
– volume: 468–470
  start-page: 214
  year: 2014
  end-page: 225
  ident: CR45
  article-title: Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: Association with disease progression and influence of immune pressure
  publication-title: Virology
  doi: 10.1016/j.virol.2014.08.009
– volume: 65
  start-page: 651
  year: 1991
  end-page: 662
  ident: CR1
  article-title: Importance of the nef gene for maintenance of high virus loads and for development of AIDS
  publication-title: Cell
  doi: 10.1016/0092-8674(91)90097-i
– volume: 156
  start-page: 1
  year: 2009
  end-page: 7
  ident: CR60
  article-title: A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants
  publication-title: J. Virol. Methods
  doi: 10.1016/j.jviromet.2008.10.012
– volume: 351
  start-page: 322
  year: 2006
  end-page: 339
  ident: CR39
  article-title: Functional characterization of HIV-1 Nef mutants in the context of viral infection
  publication-title: Virology
  doi: 10.1016/j.virol.2006.03.044
– volume: 160
  start-page: 2033
  year: 2015
  end-page: 2041
  ident: CR53
  article-title: Association between a naturally arising polymorphism within a functional region of HIV-1 Nef and disease progression in chronic HIV-1 infection
  publication-title: Arch. Virol.
  doi: 10.1007/s00705-015-2480-5
– volume: 74
  start-page: 2907
  year: 2000
  end-page: 2912
  ident: CR15
  article-title: Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation
  publication-title: J. Virol.
  doi: 10.1128/jvi.74.6.2907-2912.2000
– volume: 17
  start-page: 3
  year: 2020
  ident: CR37
  article-title: Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: A case study
  publication-title: Retrovirology
  doi: 10.1186/s12977-019-0510-1
– volume: 57
  start-page: 717
  year: 2005
  end-page: 729
  ident: CR25
  article-title: High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population
  publication-title: Immunogenetics
  doi: 10.1007/s00251-005-0048-3
– volume: 69
  start-page: 5048
  year: 1995
  end-page: 5056
  ident: CR10
  article-title: Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis
  publication-title: J. Virol.
  doi: 10.1128/JVI.69.8.5048-5056.1995
– volume: 421
  start-page: 291
  year: 2012
  end-page: 295
  ident: CR24
  article-title: Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein Vpu
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2012.04.002
– volume: 8
  start-page: 50
  year: 2011
  ident: CR58
  article-title: Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-8-50
– volume: 3
  start-page: e01754
  year: 2014
  ident: CR18
  article-title: How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4
  publication-title: Elife
  doi: 10.7554/eLife.01754
– volume: 86
  start-page: 13202
  year: 2012
  end-page: 13216
  ident: CR28
  article-title: Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1
  publication-title: J. Virol.
  doi: 10.1128/JVI.01998-12
– volume: 77
  start-page: 12430
  year: 2003
  end-page: 12440
  ident: CR30
  article-title: Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual
  publication-title: J. Virol.
  doi: 10.1128/jvi.77.23.12430-12440.2003
– volume: 7
  start-page: e01516
  year: 2016
  ident: CR59
  article-title: Relative resistance of HLA-B to downregulation by naturally occurring HIV-1 Nef sequences
  publication-title: mBio
  doi: 10.1128/mBio.01516-15
– volume: 90
  start-page: 10915
  year: 2016
  end-page: 10927
  ident: CR61
  article-title: The antagonism of HIV-1 Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor
  publication-title: J. Virol.
  doi: 10.1128/JVI.01246-16
– volume: 4
  start-page: e1000225
  year: 2008
  ident: CR27
  article-title: Phylogenetic dependency networks: Inferring patterns of CTL escape and codon covariation in HIV-1 Gag
  publication-title: PLoS Comput. Biol.
  doi: 10.1371/journal.pcbi.1000225
– volume: 526
  start-page: 212
  year: 2015
  end-page: 217
  ident: CR12
  article-title: HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation
  publication-title: Nature
  doi: 10.1038/nature15399
– year: 2019
  ident: CR20
  article-title: Plasma membrane-associated restriction factors and their counteraction by HIV-1 accessory proteins
  publication-title: Cells
  doi: 10.3390/cells8091020
– volume: 15
  start-page: 714
  year: 2005
  end-page: 723
  ident: CR4
  article-title: The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4
  publication-title: Curr. Biol.
  doi: 10.1016/j.cub.2005.02.058
– volume: 80
  start-page: 11141
  year: 2006
  end-page: 11152
  ident: CR5
  article-title: Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection
  publication-title: J. Virol.
  doi: 10.1128/jvi.01556-06
– volume: 77
  start-page: 10548
  year: 2003
  end-page: 10556
  ident: CR6
  article-title: Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles
  publication-title: J. Virol.
  doi: 10.1128/jvi.77.19.10548-10556.2003
– volume: 178
  start-page: 5513
  year: 2007
  end-page: 5523
  ident: CR55
  article-title: Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.9.5513
– volume: 16
  start-page: 6964
  year: 1997
  end-page: 6976
  ident: CR16
  article-title: Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation
  publication-title: J. Article
  doi: 10.1093/emboj/16.23.6964
– volume: 526
  start-page: 218
  year: 2015
  end-page: 223
  ident: CR13
  article-title: SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
  publication-title: Nature
  doi: 10.1038/nature15400
– volume: 77
  start-page: 1589
  year: 2003
  end-page: 1594
  ident: CR19
  article-title: Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen
  publication-title: J. Virol.
  doi: 10.1128/jvi.77.2.1589-1594.2003
– volume: 430
  start-page: 310
  year: 2018
  end-page: 321
  ident: CR50
  article-title: Remodeling of HIV-1 Nef structure by Src-family kinase binding
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2017.12.008
– volume: 296
  start-page: 1439
  year: 2002
  end-page: 1443
  ident: CR63
  article-title: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level
  publication-title: Science
  doi: 10.1126/science.1069660
– volume: 12
  start-page: 65
  year: 2010
  end-page: 70
  ident: CR49
  article-title: Role of HIV-1 Nef protein for virus replication in vitro
  publication-title: Microbes Infect.
  doi: 10.1016/j.micinf.2009.09.009
– volume: 74
  start-page: 5310
  year: 2000
  end-page: 5319
  ident: CR32
  article-title: Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions
  publication-title: J. Virol.
  doi: 10.1128/jvi.74.11.5310-5319.2000
– volume: 2
  start-page: 163
  year: 2000
  end-page: 167
  ident: CR17
  article-title: HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes
  publication-title: Nat. Cell Biol.
  doi: 10.1038/35004038
– volume: 9
  start-page: P269
  year: 2012
  ident: CR26
  article-title: HLA-associated viral polymorphism in chronically HIV-1-infected Japanese cohort: Analysis of four-digit HLA allele level
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-9-s2-p269
– volume: 100
  start-page: 278
  year: 2019
  end-page: 288
  ident: CR52
  article-title: The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists
  publication-title: J. Gen. Virol.
  doi: 10.1099/jgv.0.001201
– volume: 4
  start-page: e6687
  year: 2009
  ident: CR62
  article-title: HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins
  publication-title: PloS ONE
  doi: 10.1371/journal.pone.0006687
– volume: 68
  start-page: 2906
  year: 1994
  end-page: 2914
  ident: CR9
  article-title: Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene
  publication-title: J. Virol.
  doi: 10.1128/JVI.68.5.2906-2914.1994
– volume: 29
  start-page: 1449
  year: 2019
  end-page: 1457
  ident: CR23
  article-title: Natural HIV-1 Nef polymorphisms impair SERINC5 downregulation activity
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2019.10.007
– year: 2018
  ident: CR47
  article-title: Resistance of major histocompatibility complex class B (MHC-B) to Nef-mediated downregulation relative to that of MHC-A is conserved among primate lentiviruses and influences antiviral T cell responses in HIV-1-infected individuals
  publication-title: J. Virol.
  doi: 10.1128/JVI.01409-17
– volume: 394
  start-page: 329
  year: 2009
  end-page: 342
  ident: CR48
  article-title: HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2009.09.047
– volume: 275
  start-page: 23097
  year: 2000
  end-page: 23105
  ident: CR34
  article-title: The human thioesterase II protein binds to a site on HIV-1 Nef critical for CD4 down-regulation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M000536200
– volume: 88
  start-page: 10200
  year: 2014
  end-page: 10213
  ident: CR44
  article-title: Impaired Nef function is associated with early control of HIV-1 viremia
  publication-title: J. Virol.
  doi: 10.1128/JVI.01334-14
– volume: 82
  start-page: 1166
  year: 2008
  end-page: 1174
  ident: CR40
  article-title: A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2
  publication-title: J. Virol.
  doi: 10.1128/JVI.01874-07
– volume: 89
  start-page: 9639
  year: 2015
  end-page: 9652
  ident: CR46
  article-title: Differential ability of primary HIV-1 Nef isolates to downregulate HIV-1 entry receptors
  publication-title: J. Virol.
  doi: 10.1128/JVI.01548-15
– volume: 180
  start-page: 1107
  year: 2008
  end-page: 1116
  ident: CR22
  article-title: CTL-mediated selective pressure influences dynamic evolution and pathogenic functions of HIV-1 Nef
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.2.1107
– volume: 17
  start-page: 82
  year: 2011
  ident: 76375_CR41
  publication-title: J. Neurovirol.
  doi: 10.1007/s13365-010-0001-6
– volume: 65
  start-page: 651
  year: 1991
  ident: 76375_CR1
  publication-title: Cell
  doi: 10.1016/0092-8674(91)90097-i
– volume: 21
  start-page: 676
  year: 2005
  ident: 76375_CR54
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bti079
– volume: 421
  start-page: 291
  year: 2012
  ident: 76375_CR24
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2012.04.002
– year: 2018
  ident: 76375_CR47
  publication-title: J. Virol.
  doi: 10.1128/JVI.01409-17
– volume: 86
  start-page: 13202
  year: 2012
  ident: 76375_CR28
  publication-title: J. Virol.
  doi: 10.1128/JVI.01998-12
– volume: 394
  start-page: 329
  year: 2009
  ident: 76375_CR48
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2009.09.047
– volume: 439
  start-page: 74
  year: 2013
  ident: 76375_CR43
  publication-title: Virology
  doi: 10.1016/j.virol.2013.02.005
– volume: 68
  start-page: 2906
  year: 1994
  ident: 76375_CR9
  publication-title: J. Virol.
  doi: 10.1128/JVI.68.5.2906-2914.1994
– volume: 187
  start-page: 684
  year: 2011
  ident: 76375_CR29
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1100316
– volume: 9
  start-page: P269
  year: 2012
  ident: 76375_CR26
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-9-s2-p269
– volume: 69
  start-page: 579
  year: 1995
  ident: 76375_CR11
  publication-title: J. Virol.
  doi: 10.1128/JVI.69.1.579-584.1995
– volume: 430
  start-page: 310
  year: 2018
  ident: 76375_CR50
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2017.12.008
– volume: 292
  start-page: 6014
  year: 2017
  ident: 76375_CR14
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M117.777714
– volume: 34
  start-page: 1325
  year: 2020
  ident: 76375_CR36
  publication-title: Aids
  doi: 10.1097/QAD.0000000000002559
– volume: 351
  start-page: 322
  year: 2006
  ident: 76375_CR39
  publication-title: Virology
  doi: 10.1016/j.virol.2006.03.044
– volume: 270
  start-page: 988
  year: 1995
  ident: 76375_CR2
  publication-title: Science
  doi: 10.1126/science.270.5238.988
– volume: 104
  start-page: 6812
  year: 2007
  ident: 76375_CR33
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.0607622104
– volume: 7
  start-page: e01516
  year: 2016
  ident: 76375_CR59
  publication-title: mBio
  doi: 10.1128/mBio.01516-15
– volume: 89
  start-page: 9639
  year: 2015
  ident: 76375_CR46
  publication-title: J. Virol.
  doi: 10.1128/JVI.01548-15
– volume: 16
  start-page: 6964
  year: 1997
  ident: 76375_CR16
  publication-title: J. Article
  doi: 10.1093/emboj/16.23.6964
– volume: 10
  start-page: 1
  year: 2013
  ident: 76375_CR57
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-10-1
– volume: 82
  start-page: 1166
  year: 2008
  ident: 76375_CR40
  publication-title: J. Virol.
  doi: 10.1128/JVI.01874-07
– volume: 160
  start-page: 2033
  year: 2015
  ident: 76375_CR53
  publication-title: Arch. Virol.
  doi: 10.1007/s00705-015-2480-5
– volume: 4
  start-page: e1000225
  year: 2008
  ident: 76375_CR27
  publication-title: PLoS Comput. Biol.
  doi: 10.1371/journal.pcbi.1000225
– volume: 57
  start-page: 717
  year: 2005
  ident: 76375_CR25
  publication-title: Immunogenetics
  doi: 10.1007/s00251-005-0048-3
– volume: 90
  start-page: 10915
  year: 2016
  ident: 76375_CR61
  publication-title: J. Virol.
  doi: 10.1128/JVI.01246-16
– volume: 29
  start-page: 1449
  year: 2019
  ident: 76375_CR23
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2019.10.007
– volume: 296
  start-page: 1439
  year: 2002
  ident: 76375_CR63
  publication-title: Science
  doi: 10.1126/science.1069660
– volume: 180
  start-page: 1107
  year: 2008
  ident: 76375_CR22
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.2.1107
– volume: 17
  start-page: 3
  year: 2020
  ident: 76375_CR37
  publication-title: Retrovirology
  doi: 10.1186/s12977-019-0510-1
– volume: 77
  start-page: 12430
  year: 2003
  ident: 76375_CR30
  publication-title: J. Virol.
  doi: 10.1128/jvi.77.23.12430-12440.2003
– volume: 15
  start-page: 714
  year: 2005
  ident: 76375_CR4
  publication-title: Curr. Biol.
  doi: 10.1016/j.cub.2005.02.058
– volume: 20
  start-page: 381
  year: 2016
  ident: 76375_CR51
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2016.08.004
– volume: 10
  start-page: 100
  year: 2013
  ident: 76375_CR42
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-10-100
– volume: 8
  start-page: 50
  year: 2011
  ident: 76375_CR58
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-8-50
– volume: 12
  start-page: 65
  year: 2010
  ident: 76375_CR49
  publication-title: Microbes Infect.
  doi: 10.1016/j.micinf.2009.09.009
– volume: 468–470
  start-page: 214
  year: 2014
  ident: 76375_CR45
  publication-title: Virology
  doi: 10.1016/j.virol.2014.08.009
– volume: 87
  start-page: 2291
  year: 2006
  ident: 76375_CR38
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.81775-0
– volume: 100
  start-page: 278
  year: 2019
  ident: 76375_CR52
  publication-title: J. Gen. Virol.
  doi: 10.1099/jgv.0.001201
– volume: 2
  start-page: 338
  year: 1996
  ident: 76375_CR8
  publication-title: Nat. Med.
  doi: 10.1038/Nm0396-338
– volume: 178
  start-page: 5513
  year: 2007
  ident: 76375_CR55
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.9.5513
– volume: 76
  start-page: 853
  year: 1994
  ident: 76375_CR3
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90360-3
– volume: 88
  start-page: 10200
  year: 2014
  ident: 76375_CR44
  publication-title: J. Virol.
  doi: 10.1128/JVI.01334-14
– volume: 275
  start-page: 23097
  year: 2000
  ident: 76375_CR34
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M000536200
– volume: 3
  start-page: e94
  year: 2007
  ident: 76375_CR21
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.0030094
– volume: 4
  start-page: e6687
  year: 2009
  ident: 76375_CR62
  publication-title: PloS ONE
  doi: 10.1371/journal.pone.0006687
– volume: 80
  start-page: 11141
  year: 2006
  ident: 76375_CR5
  publication-title: J. Virol.
  doi: 10.1128/jvi.01556-06
– volume: 69
  start-page: 5048
  year: 1995
  ident: 76375_CR10
  publication-title: J. Virol.
  doi: 10.1128/JVI.69.8.5048-5056.1995
– volume: 526
  start-page: 218
  year: 2015
  ident: 76375_CR13
  publication-title: Nature
  doi: 10.1038/nature15400
– volume: 77
  start-page: 1589
  year: 2003
  ident: 76375_CR19
  publication-title: J. Virol.
  doi: 10.1128/jvi.77.2.1589-1594.2003
– volume: 2
  start-page: 163
  year: 2000
  ident: 76375_CR17
  publication-title: Nat. Cell Biol.
  doi: 10.1038/35004038
– volume: 3
  start-page: e01754
  year: 2014
  ident: 76375_CR18
  publication-title: Elife
  doi: 10.7554/eLife.01754
– volume: 526
  start-page: 212
  year: 2015
  ident: 76375_CR12
  publication-title: Nature
  doi: 10.1038/nature15399
– volume: 179
  start-page: 101
  year: 1994
  ident: 76375_CR7
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.179.1.101
– year: 2019
  ident: 76375_CR20
  publication-title: Cells
  doi: 10.3390/cells8091020
– volume: 463
  start-page: 248
  year: 2015
  ident: 76375_CR56
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2015.05.038
– volume: 156
  start-page: 1
  year: 2009
  ident: 76375_CR60
  publication-title: J. Virol. Methods
  doi: 10.1016/j.jviromet.2008.10.012
– volume: 77
  start-page: 10548
  year: 2003
  ident: 76375_CR6
  publication-title: J. Virol.
  doi: 10.1128/jvi.77.19.10548-10556.2003
– volume: 74
  start-page: 5310
  year: 2000
  ident: 76375_CR32
  publication-title: J. Virol.
  doi: 10.1128/jvi.74.11.5310-5319.2000
– volume: 74
  start-page: 2907
  year: 2000
  ident: 76375_CR15
  publication-title: J. Virol.
  doi: 10.1128/jvi.74.6.2907-2912.2000
– volume: 79
  start-page: 632
  year: 2005
  ident: 76375_CR31
  publication-title: J. Virol.
  doi: 10.1128/Jvi.79.1.632-636.2005
– volume: 81
  start-page: 13852
  year: 2007
  ident: 76375_CR35
  publication-title: J. Virol.
  doi: 10.1128/jvi.00904-07
SSID ssj0000529419
Score 2.3660448
Snippet HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 19416
SubjectTerms 631/250/255/1901
631/326/596/1787
631/326/596/2555
631/326/596/2557
631/326/596/2558
CCR5 protein
CD4 antigen
CD4 Antigens - metabolism
Cell Line
Cell-mediated immunity
Cells, Cultured
CXCR4 protein
Genotypes
Histocompatibility antigen HLA
HIV
HIV Infections - metabolism
HIV Infections - pathology
HIV-1 - pathogenicity
HLA-B Antigens - genetics
HLA-B Antigens - metabolism
Human immunodeficiency virus
Humanities and Social Sciences
Humans
Immune Evasion - genetics
Immune Evasion - physiology
Infectivity
Leukocytes, Mononuclear - metabolism
Lymphocytes
Membrane Glycoproteins - genetics
Membrane Glycoproteins - metabolism
Membrane Proteins - genetics
Membrane Proteins - metabolism
multidisciplinary
Mutation
nef Gene Products, Human Immunodeficiency Virus - genetics
nef Gene Products, Human Immunodeficiency Virus - metabolism
Nef protein
Plasma
Science
Science (multidisciplinary)
Viral Load - genetics
Viral Load - physiology
Viremia
Viremia - metabolism
Viremia - virology
Virions
Virus Replication - genetics
Virus Replication - physiology
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB7BIiQuqDxaArRyJW7UbR52nByqqkJFC1K5wCJukRPbIhJkYbOw7L_vOE6CtjwOOUT2OLFnJvM5ngfAQaQMGl2VUO3LnDI0CVQGgaQmFb6KI4061nj5nsXDETu94ldL0JU7ahewfnVrZ-tJjSY335_u579Q4X-6kPHkR41GyAaK4UYItUVwOluGFbRMwlY0-NvCfZfrO0xZkLaxM6-TLtqnF6Dzpe_kfweojV06_gDrLaAkv50EbMCSrjZh1ZWYnG9BfYL6jp81RVxC7jkZG3KmDZmOSVMnQtswKXJuU0sdcVLWRLYMQxL7k5ZMbHJXvLlDnH0rySMOdltKUlZkeHJJnTMXNpd9ZFe9DaPjPxdHQ9oWWqAFE2xKEeMkXIVKc6GZ0IGvjFaMSeXzQuiEFSpHXKFNoU1iAmY4L8IiRfvHIuRmwaOPMKjGld4BksuYI4XwTZIwE0scIw95xJUUaWwC7UHQLW9WtFnIbTGMm6w5DY-SzLEkQ5ZkDUuymQeHPc2dy8Hxbu_9jmtZJ05ZiDaYc7xSD772zahJ9nhEVnr8YPvYSkQcEZMHnxyT-8dFCLMiP8UWscD-voPN0r3YUpXXTbZuEds9pu_Bt05Qnl_r7Vnsvj-LPVgLrdA2_oj7MJhOHvRnREfT_Esj8v8AxnAMgw
  priority: 102
  providerName: Scholars Portal
– databaseName: HAS SpringerNature Open Access 2022
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB5RVpV6QTz6CC8ZqTdqNYntODmuEGh3D3sBKm6RE9tqpJJFZCni3zN2Hmi7BYlDDtF4HCfjyYztmW8AvjNt0ejqlJpQFZSjSaAqihS1mQx1wgzqmI_ynSeTaz67ETcbEPe5MD5o30Na-t90Hx32s0FD45LBcLGDGiEFffwAIwfVjnN7NB7PLmfDzoo7u-JR1mXIhCz9D_OqFVpzLdcjJP85JvXW52Ibtjq3kYzbge7Ahql34WNbSPJpD5opajX-vDRpYbefyMKSubFkuSC-GoRxyVDk0gFInQlSNUR1YkEWtxVL7h2EK97coTd9q8hf7Oy2UqSqyWT6i7YhW0iuhvyt5jNcX5xfnU1oV06BllzyJUVPJhU61kZIw6WJQm2N5lzpUJTSpLzUBXoPxpbGpjbiVogyLjO0cpyhzErBvsBmvajNNyCFSgRyyNCmKbeJwj6KWDChlcwSG5kAov7z5mWHNe5KXvzJ_Zk3S_NWJDmKJPciyR8DOB147lqkjTdbH_ZSyzuta_IYLa0QeGUBnAxk1Bd3CKJqs3hwbVy9IYF-UQBfWyEPj2PoTLEwQ4pcEf_QwGFxr1Lq6rfH5JaJW0mGAfzoJ8rLsF5_i_33NT-AT7GbxD4K8RA2l_cP5gh9omVx3CnBM6gkCMQ
  priority: 102
  providerName: Springer Nature
Title Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals
URI https://link.springer.com/article/10.1038/s41598-020-76375-w
https://www.ncbi.nlm.nih.gov/pubmed/33173092
https://www.proquest.com/docview/2471557159
https://www.proquest.com/docview/2459625822
https://pubmed.ncbi.nlm.nih.gov/PMC7656250
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExIviG8CozISb2Atie3YeUKl2tRVokKMob5Fjj9EJJaUpWPaf8_ZcTOViT0kUWM7TfK7813uzncIvafGgdA1kthU1YSBSCAqyxRxpUhNQS3wWIjyXRbzM7ZY8VU0uPUxrHI7J4aJ2nTa28gPc5hFOYet_LT-TXzVKO9djSU07qN9n7rMU7VYidHG4r1YLCvjWpmUysMe5JVfUwbfTMBYgpOrXXl0S8m8HSv5j8M0yKHjx-hRVCDxdED8Cbpn26fowVBS8voZ6k-Av2EaM3hIwH2NO4eX1uFNh0NdCOuXReFTn0pqxnHTYxUBgiHeKIsvfDJX-LEGvfpc4T9wsfNG4abF85MfZAjeguZmXMnVP0dnx0ffZ3MSCysQzQTbENBpJDe5sVxYJmyWGmcNY8qkXAsrmTY16BHWaeuky5jjXOe6BHnHKKCnOX2B9tquta8QrlXBYYRInZTMFQquUeeccqNEWbjMJijbvt5Kx6zjvvjFryp4v6msBkgqgKQKkFRXCfowjlkPOTfu7H2wRa2K_NdXN9SSoHdjM3COd4eo1naXvo-vPMRBQ0rQywHk8e8oqFU0LaFF7MA_dvBZuXdb2uZnyM4tCv9NmSbo45ZQbm7r_0_x-u6neIMe5p5oQ_zhAdrbXFzat6ANbepJIPkJ2p9OF6cLOH4-Wn79BmdnxWwSLAyw_8LkX2chDuM
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw9KkqQnBB7A0UMBKcwGoWO04OCKFCNUPLXGjR3IIT2yISTYZmymh-im_kvWzVUNFbDzlEthPbb7XfBvAqMg6Frkm49XXOBYoEroNAc5cq38SRRRprvXxn8eREfJ7L-Rb8GWJhyK1y4IktozZ1QXfkeyFyUSnxSd8vfnGqGkXW1aGERocWh3a9wiNb8276EeH7OgwPPh3vT3hfVYAXQoklR4GeSBMaK5UVyga-cdYIoY0vC2UTUZgchah1hXWJC4STsgiLFJm9iHDqBVWJQJZ_AwWvT4c9NVfjnQ5ZzUSQ9rE5fpTsNSgfKYYNz2hIyEry1ab8u6TUXvbN_MdA28q9g7twp1dY2YcOw-7Blq3uw82uhOX6ATRT5CfINg3rEn6vWe3YzDq2rFlbh8JSGBb7Sqmr9iUrG6Z7hMAhdAnMzih5LL4sUI8_1ew3fuy01Kys2GT6jXfOYthcjpFjzUM4uZYtfwTbVV3ZHWC5jiWOUL5LEuFijd_IQxlJo1Uau8B6EAzbmxV9lnMqtvEza63tUZJ1IMkQJFkLkmzlwZtxzKLL8XFl790BallP7012gZ0evBybkVLJ_KIrW59TH6p0JFEj8-BxB-TxdxGqcZGfYovaAP_YgbKAb7ZU5Y82G7iK6Qzre_B2QJSLaf1_FU-uXsULuDU5_nKUHU1nh0_hdkgI3Po-7sL28uzcPkNNbJk_b9Gfwffrpre_uqZG6A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw9KmaCsQFsRMoYCQ4gTVZ7Dg5IARtRzMUjSqgqDfXiW0RiSZDM2U0v8bX8ZytGip66yGHyEtiv9V-G8CrSFsUujqhxlcZZSgSqAoCRW0qfB1HBmms8fKdx9Mj9umYH2_Bnz4WxrlV9jyxYdS6yt0d-ThELso5PunYdm4Rh3uT94tf1FWQcpbWvpxGiyIHZr3C41v9braHsH4dhpP9b7tT2lUYoDkTbElRuCdch9pwYZgwga-t0Ywp7fNcmITlOkOBamxubGIDZjnPwzxFxs8iXEbuKkYg-98W7lQ0gu2P-_PDL8MNj7OhsSDtInX8KBnXKC1dRBue2JCsBaerTWl4ScW97Kn5j7m2kYKTO3C7U1_Jhxbf7sKWKe_Bjbag5fo-1DPkLshENWnTf69JZcncWLKsSFOVwrigLPLVJbLa5aSoierQA4e4K2Fy5lLJ4ssCtfpTRX7jZKeFIkVJprPvtHUdw-ZiiCOrH8DRtWz6QxiVVWkeA8lUzHGE8G2SMBsrnCMLecS1EmlsA-NB0G-vzLuc5670xk_Z2N6jRLYgkQgS2YBErjx4M4xZtBk_ruy900NNdtRfywtc9eDl0Ix064wxqjTVuevj6h5x1M88eNQCefhchEpd5KfYIjbAP3RwOcE3W8riR5MbXMTuROt78LZHlIvf-v8qnly9ihdwE2lNfp7ND57CrdDhb-MIuQOj5dm5eYZq2TJ73uE_gZPrJrm_b2JMgw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impaired+ability+of+Nef+to+counteract+SERINC5+is+associated+with+reduced+plasma+viremia+in+HIV-infected+individuals&rft.jtitle=Scientific+reports&rft.au=Toyoda+Mako&rft.au=Kamori+Doreen&rft.au=Tan%2C+Toong+Seng&rft.au=Kageaki%2C+Goebuchi&rft.date=2020-11-10&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=10&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-020-76375-w&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon